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Summary
Background Tuberculosis elimination strategies in Brazil might neglect adolescents and young adults aged 10–24 years, 
hampering tuberculosis control. However, little is known about factors associated with tuberculosis treatment 
outcomes in this underserved group. In this study, we aimed to investigate social and health factors associated with 
unfavourable treatment outcomes in young people with tuberculosis in Brazil.
Methods A national retrospective cohort study was done using data from Sistema de Informação de Agravos de 
Notificação (SINAN), the national tuberculosis registry in Brazil. People aged 10–24 years (young people) with 
tuberculosis registered in SINAN between Jan 1, 2015, and Dec 31, 2018, were included. Unfavourable outcomes were 
defined as loss to follow-up, treatment failure, and death. Favourable outcome was defined as treatment success. 
Multiple logistic regression models estimated the association between social and health factors and tuberculosis 
treatment outcomes.
Findings 67 360 young people with tuberculosis were notified to SINAN, and we included 41 870 young people in our 
study. 7024 (17%) of the 41 870 included individuals had unfavourable treatment outcomes. Young people who 
received government cash transfers were less likely to have an unfavourable outcome (adjusted odds ratio 0·83, 
95% CI 0·70–0·99). Homelessness (3·03, 2·07–4·42), HIV (2·89, 2·45–3·40), and illicit drug use (2·22, 1·93–2·55) 
were the main factors associated with unfavourable treatment outcome.
Interpretation In this national cohort of young people with tuberculosis in Brazil, tuberculosis treatment success 
rates were lower than WHO End TB Strategy targets, with almost a fifth of participants experiencing unfavourable 
treatment outcomes. Homelessness, HIV, and illicit drug use were the main factors associated with unfavourable 
outcome. In Brazil, strategies are required to support this underserved group to ensure favourable tuberculosis 
treatment outcomes.
Funding Wellcome Trust, UK Medical Research Council, and UK Foreign Commonwealth and Development Office.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction 
Tuberculosis is a disease of poverty, which dispro­
portionately affects individuals who are socially 
and economically vulnerable.1–3 Before the COVID­19 
pandemic, tuberculosis was the leading cause of death 
from a single infectious agent globally.4 Modelling studies 
have suggested that COVID­19 will probably threaten 
tuberculosis control programmes, particularly in low­
income and middle­income settings, affecting tuberculosis 
prevention, case detection, and management.5
Before the COVID­19 pandemic, WHO estimated that 
less than 70% of all new tuberculosis cases were notified 
to surveillance systems and this proportion was likely to 
be even lower among young people aged 10–24 years 
(hereafter referred to as young people; appendix p 1).4,6 
In 2018, the global burden of tuberculosis for young 
people was calculated for the first time. An estimated 
1·8 million young people developed tuberculosis disease 
in 2018, comprising 17% of all new tuberculosis cases 
worldwide.6 Compared with children, young people are 
at increased risk of tuberculosis infection, tuberculosis 
disease, and tuberculosis­related complications.7,8
The transition from adolescence to adulthood is 
associated with a cumulative increase in tuberculosis 
incidence.6 Young people are more likely to develop 
infectious forms of tuberculosis than children under 
5 years of age, independent of HIV status.9,10 Moreover, 
young people have greater potential to contribute to 
onward tuberculosis transmission, which not only 
relates to an increased likelihood of infectious pulmonary 
tuberculosis but also to engagement with wider social 
networks and attendance at educational institutions 
and activity in the labour market, with the highest risk 
of transmission between 12 and 24 years of age.7–9,11 
However, young people are often overlooked in national 
tuberculosis treatment and prevention strategies, with 
tuberculosis treatment programmes mostly focusing on 
adults and prevention strategies prioritising children 
under 5 years.6,12 Even in countries with high tuberculosis 
burden, health­care providers might often perceive 
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tuberculosis as a disease that seldom affects young 
people.13
Approximately nine in ten young people live in low­
income and middle­income countries, many of which are 
also countries with high tuberculosis burden.13,14 Brazil, an 
upper­middle­income country, is among the 30 countries 
with the highest burden of tuberculosis globally.4 In Brazil, 
between 2015 and 2018, 67 360 (19%) of the 357 155 total 
tuberculosis cases were among young people.15,16 However, 
there are no specific public health policies targeting young 
people with tuberculosis in Brazil. Moreover, there are no 
nationally representative longitudinal studies evaluating 
the factors associated with unfavourable treatment 
outcomes for young people with tuberculosis in this 
context. Doing such research is of importance not only 
from a human rights perspective but also because 
unfavourable tuberculosis treatment outcomes for young 
people increases the likelihood of onward tuberculosis 
transmission, tuberculosis­related morbidity and mor­
tality, and adverse socioeconomic outcomes.
Using prospective clinical registry data derived from 
Sistema de Informação de Agravos de Notificação 
(SINAN), the Brazilian national tuberculosis registry and 
one of the largest of its kind in the world, we sought to 
investigate the social and health factors associated with 
unfavourable treatment outcomes among young people 
with new tuberculosis diagnosis in Brazil.
Methods 
Study design and participants 
We did a national retrospective cohort study of young 
people with tuberculosis in Brazil, using de­identified 
registry data derived from SINAN, the Brazilian national 
tuberculosis registry.16,17 Study inclusion criteria were 
defined as all individuals aged 10–24 years, referred to as 
young people, notified to SINAN with a new diagnosis of 
tuberculosis between Jan 1, 2015, and Dec 31, 2018. This 
definition of young people has been used by the United 
Nations Population Fund,14 and in related studies.6 We 
excluded individuals who were notified to SINAN due to 
tuberculosis recurrence or return following loss to 
follow­up, those who had a tuberculosis diagnosis at 
post­mortem examination, and those who had a missing 
notification status. We also excluded individuals who had 
missing treatment outcomes (still undergoing 
treatment), those whose outcome was recorded as 
transfer to other health­care centre, those whose 
diagnosis changed during tuberculosis treatment, or 
those whose outcome was recorded as drug­resistant 
tuberculosis. The outcomes of individuals with drug­
resistant tuberculosis at time of notification were not 
recorded in SINAN but rather in a separate registry 
(Special Treatment of Tuberculosis Information 
System).18 Therefore, outcomes of young people with 
drug­resistant tuberculosis were not included in this 
study.
This study was done under the Declaration of 
Helsinki, and adheres to Brazilian, Swedish, and UK 
research regulations on the use of de­identified 
secondary data for research. SINAN is an open­access 
data platform, which seeks to democratise public health 
research in Brazil. The main supervising institution 
(Karolinska Institutet) waived the need for formal ethics 
approval given the use of de­identified, secondary level 
Research in context
Evidence before this study
We used Google Scholar, PubMed, and Embase to search for 
papers that were published in Portuguese and English between 
database inception and Jan 1, 2021, and that evaluate young 
people with tuberculosis in Brazil, using the terms 
“Tuberculosis”, “TB”, “Young People”, “Adolescents”, “Young 
Adults”, “Unfavourable Treatment Outcome”, “Adverse 
Treatment Outcome”, “Loss to Follow Up”, “Death”, “Brazil”, 
“High Burden Country”, “TB Incidence Rates”. The studies 
identified from this search were restricted either to paediatric or 
adolescent populations and did not include updated variables 
on social and health vulnerability in their analyses (deprivation 
of liberty, homelessness, illicit drug use, tobacco use, and 
government cash transfers).
Added value of this study
To our knowledge, this study is the first nationally 
representative analysis of the characteristics of young people 
(aged 10–24 years) with tuberculosis in Brazil and evaluation of 
the factors associated with unfavourable tuberculosis treatment 
outcomes in this age group. The study used population-level 
clinical registry data retrieved from an updated version of the 
national Brazilian diseases registry (Sistema de Informação de 
Agravos de Notificação). The study found that tuberculosis 
treatment success rates were lower than WHO End TB Strategy 
targets with almost a fifth of participants experiencing 
unfavourable outcome. Homelessness, HIV, and illicit drug use 
were the main factors associated with unfavourable outcome. 
Young people who received government cash transfers were less 
likely to have unfavourable outcomes.
Implications of all the available evidence
This study contributes to a growing evidence base that young 
people with tuberculosis need greater attention in national 
tuberculosis control programmes, which is particularly relevant 
for policy makers, health-care providers, and civil society 
representatives. The findings emphasise the need for 
individualised, patient-centred tuberculosis care for young 
people, and indicate the potential for targeted social support 
and protection strategies to increase treatment success of 
young people with tuberculosis.
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registry data. Tuberculosis notifications to SINAN are 
not linked to other registries, and therefore there is 
minimal risk of the dataset being used to derive, 
ascertain, or disclose any further patient­identifiable 
information.18
Study context 
Tuberculosis is a mandatory notifiable infectious disease 
in Brazil, and the Sistema Único de Saúde (SUS), Brazil’s 
national public health­care system, provides free and 
accessible tuberculosis treatment at the point of care 
throughout Brazil in coordination with the Programa 
Nacional de Controle da Tuberculose (the National 
Tuberculosis Control Programme). However, geographical 
and regional disparities in tuberculosis services, care, and 
treatment outcomes persist, and these disparities are 
even observed at a macroregional level (north, northeast, 
centre­west, southeast, and south).19 Of concern, SUS is 
under increasing pressure in the context of economic and 
political shocks since 2016, most recently including the 
COVID­19 pandemic and preceding economic crises and 
severe austerity measures.20 In conjunction with SUS, 
Programa Bolsa Família, the largest government social 
protection programme globally, strives to reduce the 
burden of poverty in Brazil and secondarily might reduce 
the risk of out­of­pocket expenditure and catastrophic 
health costs for Brazilians who become unwell, including 
those who fall ill with tuberculosis.21
SINAN is a decentralised system in Brazil and consists 
of clinical notifications for specified notifiable diseases.16,17 
The surveillance system was first conceived in 1990 
and represents one of the largest national tuberculosis 
registries among countries with high tuberculosis burden, 
providing valuable data on tuberculosis epidemiology for 
researchers and health professionals.
With reference to the conceptual framework from 
Maciel and Reis­Santos, which comprises three axes of 
individual, social, and institutional vulnerability,22 
particular social and health variables were extracted 
from SINAN. These variables were: (1) individual 
vulnerability variables: age, sex, skin colour, tobacco use, 
alcohol misuse, illicit drug use, and HIV or AIDS status; 
(2) social vulnerability variables: extent of urbanisation, 
region of Brazil, educational attainment, inclusion 
in government cash transfers, homelessness, and 
deprivation of liberty; and (3) institutional vulnerability 
variables: chest radiography findings, baseline smear 
microscopy, clinical features of tuberculosis, treatment 
supervision, total number of contacts identified, and 
total number of contacts traced.
To standardise educational attainment by age, when 
comparing adolescents and young adults, we created a 
variable to ascertain whether the educational attainment 
of the young people was lower than expected for their 
age. As per related guidance, we assumed that all young 
people should be literate, people over 12 years of age 
should have completed 4th grade (>5 years of education), 
all young people over 16 years of age should have 
completed elementary school (>9 years of education), 
and all young people over 19 years of age should have 
completed high school (>12 years of education).23
A composite binary variable of contact tracing was 
generated by calculating the total number of contacts 
identified minus the total number of contacts traced. If 
this value was less than or equal to zero, contact tracing 
was assumed to be successfully completed (all contacts 
initially identified had been successfully contact traced, 
or additional contacts to those initially identified had 
been successfully contact traced).
Outcomes 
The main study outcome was tuberculosis treatment 
outcome: a binary categorical variable of either favourable 
or unfavourable treatment outcome. Favourable treat­
ment outcomes consisted of treatment completion and 
cure. For pulmonary tuberculosis, cure was defined as 
clinician­led discharge from tuberculosis care following 
completion of tuberculosis treatment and a minimum of 
two negative sputum smear tests, or completion of 
tuberculosis treatment in the absence of sputum smear 
microscopy;21 for extra­pulmonary tuberculosis, cure 
was defined as the completion of tuberculosis treatment 
or evidence of clinical improvement and radiological 
resolution.21 Unfavourable treatment outcome was 
Figure 1: Participant selection
SINAN=Sistema de Informação de Agravos de Notificação.
67 360 people aged 10–24 years were notified to 
SINAN with tuberculosis disease between
Jan 1, 2015, and Dec 31, 2018  
57 964 notifications to SINAN classified as new 
tuberculosis diagnosis  
41 870 participants included with known 
treatment outcomes
34 846 had favourable outcome 
7024 had unfavourable outcome
9396 excluded
2510 recurrence of tuberculosis
4713 return following loss to follow-up
1889 transfer to another health-care 
centre
133 tuberculosis diagnosis following 
post-mortem
151 missing notification type
16 094 excluded
11 948 missing treatment outcomes
3160 transferred to another 
health-centre centre
565 diagnosis changed following 
treatment 
421 drug-resistant tuberculosis 
recorded as end outcome
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defined as either (1) loss to follow­up, whereby treatment 
was disrupted for 30 days or more; (2) mortality during 
tuberculosis treatment from any cause; (3) change in 
tuberculosis treatment regimen; or (4) tuberculosis 
treatment failure, whereby sputum smear or culture was 
positive at 4 months or for 2 consecutive months after the 
4th month of tuberculosis treatment initiation.20 Final 
tuberculosis treatment outcomes were recorded within 
9 months of initial notification to SINAN, or within 
15 months for cases with central nervous system 
involvement.21
Statistical analysis 
We did univariate and multiple logistic regression 
analyses to estimate the association between social and 
health factors recorded at the time of tuberculosis 
notification and unfavourable treatment outcomes.22 
The association was estimated using crude and adjusted 
odds ratios (OR), 95% CIs, and Wald test p values. 
p values of less than 0·05 were considered statistically 
significant. In the adjusted models, we excluded all 
missing data a priori (complete­case analysis) and con­
sidered age and sex to be the main study confounders.22,24 
To test the robustness of our findings regarding the 
exclusion of missing data, we did a missing indicator 
analysis (post­hoc), including missing data as a category 
in the multiple logistic regression models. Also, 
considering that 18 years is the legal age in Brazil, we did 
stratified analyses (pre­specified) for individuals aged 
10–17 years (hereafter referred to as adolescents) and 
18–24 years (hereafter referred to as young adults) to 
test if factors associated with unfavourable treatment 
outcomes varied with age. Finally, we did an exploratory 
descriptive analysis to investigate the extent to 
which young people with tuberculosis are included 
in support strategies, including government cash 
transfers, contact tracing, and treatment supervision. 
Data management and statistical analysis were done 








Adolescents (aged 10–17 years) 8826 (21%) 1000 (14%)
Young adults (aged 18–24 years) 33 044 (79%) 6024 (86%)
Sex (n=41 867)
Female 14 521 (35%) 2034 (29%)
Male 27 346 (65%) 4989 (71%)
Skin colour (n=38 762)
White 12 666 (33%) 1725 (27%)
Black 4895 (13%) 994 (15%)
Brown 20 307 (52%) 3653 (56%)
Asian 286 (1%) 43 (1%)
Indigenous 608 (2%) 65 (1%)
Low education attainment (n=32 590)
No 15 207 (47%) 1786 (34%)
Yes 17 383 (53%) 3404 (66%)
Tobacco use (n=39 044)
No 33 301 (85%) 4890 (77%)
Yes 5743 (15%) 1489 (23%)
Alcohol misuse (n=39 424)
No 36 292 (92%) 5525 (85%)
Yes 3132 (8%) 939 (15%)
Illicit drug use (n=38 889)
No 32 913 (85%) 4502 (71%)
Yes 5976 (15%) 1871 (29%)
HIV (n=37 813)
No 35 904 (95%) 5394 (87%)
Yes 1909 (5%) 810 (13%)
Diabetes (n=39 313)
No 38 928 (99%) 6349 (99%)
Yes 385 (1%) 88 (1%)
Extent of urbanisation (n=28 521)
Rural 2692 (9%) 341 (7%)
Urban 25 503 (89%) 4740 (92%)
Peri-urban 326 (1%) 55 (1%)







(Continued from previous column)
Region of Brazil (n=41 870)
Southeast 21 184 (51%) 3440 (49%)
North 5149 (12%) 900 (13%)
Northeast 9717 (23%) 1649 (23%)
South 4337 (10%) 766 (11%)
Central-west 1483 (4%) 269 (4%)
Government cash transfers (n=22 668)
No 20 462 (90%) 3652 (92%)
Yes 2206 (10%) 321 (8%)
Homelessness (n=39 126)
No 38 714 (99%) 6227 (96%)
Yes 412 (1%) 247 (4%)
Deprivation of liberty (n=39 415)
No 33 142 (84%) 5754 (88%)
Yes 6273 (16%) 771 (12%)
Clinical features of tuberculosis (n=41 868)
Extra-pulmonary tuberculosis 4745 (11%) 726 (10%)
Pulmonary tuberculosis 37 123 (89%) 6298 (90%)
Baseline smear microscopy (n=30 408)
Negative 7239 (24%) 1124 (23%)
Positive 23 169 (76%) 3830 (77%)
Chest radiography findings (n=27 956)
Normal 1679 (6%) 240 (5%)
Abnormal 26 277 (94%) 4610 (95%)
Data are n (%).
Table 1: Social and health characteristics of participants (excluding 
missing data)
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Role of the funding source 
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report.
Results 
Between Jan 1, 2015, and Dec 31, 2018, 67 360 young 
people with tuberculosis were notified to SINAN. 
41 870 young people were included in the final study 
population, with 25 490 (38%) of notifications excluded 
using the study exclusion criteria (figure 1).
The study cohort mostly included young adults aged 
18–24 years (n=33 044; 79%), male individuals (n=27 346; 
65%), and individuals identifying with Black (n=4895; 
13%) or Brown (n=20 307; 52%) skin colour (table 1). 
Approximately half of the individuals (n=17 383; 53%) 
had lower educational attainment than their peers. 
Tobacco use (n=5743; 15%), alcohol misuse (n=3132; 8%), 
and illicit drug use (n=5976; 15%) were prevalent. 
1909 (5%) individuals had a known diagnosis of HIV at 
the time of diagnosis. Most participants lived in urban 
settings (n=25 503; 89%), and approximately half were 
living in the southeast of Brazil (n=21 184; 51%). 
2206 (10%) individuals were directly enrolled in 
government cash transfers. 8273 (16%) individuals were 
deprived of their liberty (ie, were incarcerated).
Most young people included in this study were 
diagnosed with pulmonary tuberculosis (n=37 123; 
89%). Reporting of diagnostic investigations (smear 
microscopy and chest radiography) were limited by 
missing data. However, of those with available data, 
most had abnormal chest radiography findings 
(n=26 277; 94%) or positive baseline smear microscopy 
(n=23 169; 76%). Positive baseline smear microscopy 
and abnormal chest radiography were predominantly 
seen in patients with pulmonary tuberculosis (positive 
smear microscopy: n=23 100, 99%; abnormal chest 
radiography: n=23 975, 91%).
7024 (17%) of the young people with tuberculosis 
had unfavourable treatment outcomes (table 1). The 
univariate analyses showed that the following participant 
groups had a higher likelihood of unfavourable treatment 
outcome: young adults (OR 1·74, 95% CI 1·62–1·87), 
male individuals (1·37, 1·30–1·45), those identifying 
with Black (1·62, 1·48–1·76) or Brown (1·39, 1·31–1·48) 
skin colour, those with lower educational attainment 
than peers (1·83, 1·72–1·95), those reporting tobacco 
use (2·03, 1·90–2·17), those reporting alcohol misuse 
(2·38, 2·20–2·59), those reporting illicit drug use (2·88, 
2·70–3·06), those with HIV (4·17, 3·79–4·59), those with 
diabetes (1·52, 1·20–1·93), those living in urban areas 
(1·57, 1·40–1·77), and those experiencing homelessness 
(7·81, 6·40–9·53; figure 2). Conversely, some groups 
were less likely to have an unfavourable treatment 
outcome in the univariate analyses, namely those 
identifying as Indigenous (0·76, 0·58–0·99), those 
receiving government cash transfers (0·78, 0·69–0·89), 
Figure 2: Associations between participant characteristics and unfavourable tuberculosis treatment 
outcomes
Associations were estimated by a complete case analysis (n=15 050), using univariate and multivariate logistic 
regression models. OR=odds ratio.
Age 
Adolescents (aged 10–17 years) 
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and those deprived of liberty (0·67, 0·62–0·72). In the 
adjusted complete case analysis, some groups were more 
likely to have unfavourable treatment outcomes, namely 
young adults (adjusted OR 1·34, 1·18–1·52), those 
identifying with Black (1·63, 1·41–1·89) or Brown (1·39, 
1·23–1·57) skin colour, those with lower educational 
attainment than peers (1·68, 1·53–1·85), those reporting 
tobacco use (1·25, 1·08–1·44), those reporting illicit drug 
use (2·22, 1·93–2·55), those with HIV (2·89, 2·45–3·40), 
and those experiencing homelessness (3·03, 2·07–4·42). 
Conversely, young people enrolled in government cash 
transfers (0·83, 0·70–0·99) or those deprived of their 
liberty (0·56, 0·47–0·66) were less likely to have 
unfavourable treatment outcome.
When investigating the extent to which young people 
with tuberculosis were included in individual support 
strategies (table 2), adolescents were more likely to be 
included in government cash transfers (n=880; 17%) 
than young adults (n=1326; 8%). There were similarly 
low degrees of treatment supervision in adolescents 
(n=3514; 52%) and young adults (n=13 448; 52%). 
Approximately a third of adolescents (n=2401; 31%) and 
young adults (n=8435; 29%) were included in onward 
contact tracing efforts.
In stratified analyses (table 3, table 4), the magnitude 
of association for those identifying with Black (adjusted 
OR 2·20, 95% CI 1·50–3·22) or Brown (1·61, 1·17–2·23) 
skin colour, low educational attainment (2·18, 
1·71–2·78), illicit drug use (3·32, 2·06–5·35), and HIV 
(4·63, 2·81–7·63) was greater for adolescents than 
young adults. Government cash transfers were only 
significantly associated with a smaller likelihood of 
unfavourable treatment outcome for adolescents (0·66, 
0·46–0·93). However, male sex (1·12, 1·00–1·25), 
tobacco use (1·26, 1·08–1·46), and homelessness (3·32, 
2·22–4·96) were only significantly associated with 
unfavourable treatment outcome for young adults. 
Deprivation of liberty was only protective for young 
adults (0·55, 0·47–0·65).
Discussion 
To the best of our knowledge, this study is the first 
national evaluation of young people with tuberculosis in 
Brazil. Our study population predominantly included 
male individuals, young adults, individuals identifying 
with Black or Brown skin colour, and individuals living 
in urban areas. Almost a fifth of young people with 
tuberculosis were deprived of their liberty and approxi­
mately half had lower educational attainment.
Young adults (aged 18–24 years), those identifying with 
Black or Brown skin colour, those with lower educational 
attainment, those reporting tobacco use, those reporting 
illicit drug use, those with HIV positivity, and those 
experiencing homelessness had an increased likelihood 
of unfavourable tuberculosis treatment outcome. Young 
people in receipt of government cash transfers or 
deprived of their liberty had a decreased likelihood of 
having unfavourable tuberculosis treatment outcomes. 
However, there was some discrepancy in the social and 
health factors associated with unfavourable treatment 
outcome for adolescents and young adults. Despite the 
social and health vulnerabilities of young people with 
newly diagnosed tuberculosis in Brazil, approximately 
half (52%) of the young people were provided with 
treatment supervision and a minority (10%) received 
government cash transfers.
An estimated 17% (7024 of 41 870) of young 
people with tuberculosis in this cohort had an 
unfavourable tuberculosis treatment outcome, which 
falls behind the WHO End TB Strategy targets.15 However, 
the rate of unfavourable treatment outcome in young 
people observed in this study is still lower than the rate 
observed in individuals notified with tuberculosis over 
the past decade in Brazil (202 713 [21%] of 970 774 
individuals between 2010 and 2020).16 Other studies have 
found that the proportion of tuberculosis­related deaths 
continually increases from childhood (<10 years) to older 
adulthood (≥50 years), with a substantially higher rate of 
atypical features of tuberculosis, more adverse drug 
reactions, and higher tuberculosis­related mortality for 
older adults (≥65 years) than their younger counterparts 
(<65 years), which might in part explain our findings.25,26 
It is also possible that the underdiagnosis or under­
reporting of disseminated tuberculosis could explain the 
lower mortality rate observed in young people, as seen in 
another study in the Philippines.27 Finally, there might 
be discrepancies in the definition of unfavourable 
tuberculosis treatment outcome contributing to the 
variation seen across studies.
Consistent with other studies, we found that new cases 
of tuberculosis and likelihood of unfavourable outcome 
were highest in young adults.13 The overarching majority 
of new cases occurred in male individuals. However, 
being male was only significantly associated with an 
increased likelihood of unfavourable treatment outcome 
for young adults. In the adult population, men are at a 
substantially higher risk of contracting and dying from 
Adolescents (10–17 years) Young adults (18–24 years)
Government cash transfers* (n=22 668)
No 4185 (83%) 16 277 (92%)
Yes 880 (17%) 1326 (8%)
Contact tracing done (n=36 867)
No 2401 (31%) 8435 (29%)
Yes 5418 (69%) 20 613 (71%)
Treatment supervision provided (n=32 640)
No 3241 (48%) 12 437 (48%)
Yes 3514 (52%) 13 448 (52%)
Data are n (%). *For the government cash transfer variable, there were similar 
proportions of missing data for both adolescents (43% [3761/8826] missing 
data) and young adults (47% [15 441/33 044] missing data).
Table 2: The inclusion of adolescents and young adults with tuberculosis 
in individual support strategies (excluding missing data)
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tuberculosis than women, whereas women face distinct 
challenges to access tuberculosis services and care, 
including stigma.28,29
Our study findings with respect to skin colour and race 
were similar to other studies that showed that those 
identifying with Black or Brown skin colour had higher 
odds of loss to follow­up and death from tuberculosis 
in Brazil than those with White skin colour.22 These 
findings probably relate to structural racism that persists 
for people identifying with Black or Brown skin colour, 
with respect to education, employment, occupation, and 
income level, which are distal determinants of 
tuberculosis.30 Concerningly, the association between 
race and unfavourable treatment outcome persisted for 
both adolescents and young adults in stratified analyses, 
emphasising the need for an intersectional approach 
from policy makers and clinicians.
Low educational attainment was associated with 
unfavourable treatment outcome in this study, and the 
direction and magnitude of this association persisted for 
both adolescents and young adults in stratified analyses. 
Similarly, among adults with tuberculosis, participation 
or completion of higher education was associated with 
lower likelihood of loss to follow­up compared to those 
who had not completed higher education.22 Indeed, 
secure employment, higher income level, and higher 
socioeconomic status are largely determined by education 
level. Other studies have also emphasised the importance 
of health literacy in the context of tuberculosis infection, 
especially in high­burden settings reliant on passive 
case finding. One study in Lima, Peru, found that key 
determinants of tuberculosis­related health literacy were 
occupation and socioeconomic status, with patients 
living in poverty being four times more likely to have low 
health literacy than those not living in poverty.31 The 
effect of tuberculosis infection, time spent at appoint­
ments, and tuberculosis treatment on a young person’s 
educational attainment, onward employment, and 
income level are also highly relevant, but beyond the 
remit of this study.
The prevalence of illicit drug use was relatively high in 
our cohort and appeared to be more common than 
alcohol misuse. These findings are substantiated by 
downward trends in alcohol consumption for adolescents 
attending public schools in Brazil between 1989 and 
2010.32 Accordingly, drug use is probably increasingly 
relevant for young people with tuberculosis. Deiss and 
colleagues33 also described the increasing burden of 
tuberculosis for urban subpopulations, in particular 
people who use drugs, and found that those using illicit 
Adolescents aged 
10–17 years (n=3862)
Young adults aged 
18–24 years (n=12 966)
Sex 
Female 1 (ref) 1 (ref)
Male 0·94 (0·76–1·16) 1·13 (1·02–1·26)
Skin colour 
White 1 (ref) 1 (ref) 
Black 2·07 (1·44–2·98) 1·44 (1·24–1·68)
Brown 1·73 (1·28–2·34) 1·32 (1·17–1·50)
Asian 2·54 (0·92–7·03) 0·88 (0·49–1·56)
Indigenous 0·77 (0·33–1·79) 0·79 (0·46–1·36)
Low educational attainment 
No 1 (ref) 1 (ref) 
Yes 2·06 (1·64–2·59) 1·62 (1·47–1·79)
Tobacco use 
No 1 (ref) 1 (ref) 
Yes 1·19 (0·73–1·93) 1·27 (1·10–1·46)
Alcohol misuse
No 1 (ref) 1 (ref) 
Yes 0·94 (0·53–1·68) 1·12 (0·95–1·31)
Illicit drug use
No 1 (ref) 1 (ref) 
Yes 3·66 (2·36–5·70) 2·11 (1·84–2·42)
HIV
No 1 (ref) 1 (ref) 
Yes 4·52 (2·85–7·17) 2·80 (2·39–3·29)
Diabetes
No 1 (ref) 1 (ref) 
Yes 1·19 (0·44–3·22) 1·40 (0·91–2·14)
Extent of urbanisation
Rural 1 (ref) 1 (ref) 
Urban 1·13 (0·75–1·70) 1·29 (1·06–1·57)
(Table 3 continues in next column)
Adolescents aged 
10–17 years (n=3862)
Young adults aged 
18–24 years (n=12 966)
(Continued from previous column)
Peri-urban 0·79 (0·16–3·93) 1·27 (0·81–2·01)
Region
Southeast 1 (ref) 1 (ref)
North 0·83 (0·62–1·13) 0·96 (0·83–1·11)
Northeast 0·84 (0·63–1·11) 0·83 (0·73–0·94)
South 0·92 (0·65–1·31) 0·94 (0·81–1·09)
Central-west 1·62 (0·97–2·73) 1·02 (0·81–1·29)
Homelessness
No 1 (ref) 1 (ref) 
Yes 1·13 (0·33–3·86) 3·52 (2·38–5·21)
Deprivation of liberty
No 1 (ref) 1 (ref) 
Yes 1·15 (0·53–2·52) 0·56 (0·48–0·66)
Clinical features of tuberculosis
Extra-pulmonary 
tuberculosis
1 (ref) 1 (ref) 
Pulmonary tuberculosis 0·71 (0·54–0·94) 0·97 (0·83–1·13)
Data are adjusted odds ratio (95% CI). Associations were estimated by complete 
case analyses of adolescents and young adults (excluding the government cash 
transfers variable), using multivariate logistic regression models.ç
Table 3: Associations between participant characteristics and 
unfavourable tuberculosis treatment outcomes—excluding the 
government cash transfers variable
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drugs have physiological, environmental, and social 
risk factors that increase their likelihood of onward 
tuberculosis transmission, loss to follow­up, and death 
during treatment. There is evidently a diversity of illicit 
drug use in terms of type of drug taken, quantity used, 
and regularity of use. These different drug use 
practices might be associated with a range of risk factors 
and consequences, and hence require various different 
potential mitigation strategies. Therefore, it would 
be useful to better understand the specific drug use 
practices and their distinct associations with unfavourable 
treatment outcome for young people.
5·05% of our study population was HIV positive, as 
compared with a prevalence of 0·04% in Brazil. There is 
little evidence showing the prevalence of tuberculosis–
HIV co­infection among young people worldwide, with 
HIV­positive estimates varying between 10% and 60% for 
younger children with tuberculosis.34 In this study, young 
people with HIV had approximately three times higher 
odds of unfavourable tuberculosis treatment outcome. 
Our finding that HIV­co­infection was associated with 
an increased likelihood of unfavourable tuberculosis 
treatment outcome is similar to that of other studies.35 
A systematic review of prediction models for pulmonary 
tuberculosis outcomes in adults also found that HIV was 
a common predictor of unfavourable treatment outcome.36 
Tubercu losis accounts for a quarter of HIV­related deaths 
globally, and management and care of young people 
with tuberculosis–HIV co­infection is often challenging, 
especially among those with advanced HIV.37,38 Improved 
access to well integrated tuberculosis and HIV services is 
crucial to improve outcomes for people living with HIV 
and diagnosed with tuberculosis, especially for affected 
adolescents and young adults.
Experiencing homelessness was strongly associated 
with unfavourable treatment outcome in this study, 
although the effect size persisted only for young adults 
in the stratified analyses. It is possible that there are 
hidden confounding variables influencing the association 
between homelessness and treatment outcome; home­
less ness might be considered an extreme life condition 
for young adults, and might relate to lack of shelter, 
malnutrition, overcrowding, and extreme poverty.39 
Similar findings have previously been reported for adults 
with tuberculosis who are experiencing homelessness: in 
Adolescents aged 
10–17 years (n=3431)
Young adults aged 
18–24 years (n=11 619)
Sex 
Female 1 (ref) 1 (ref)
Male 1·04 (0·82–1·30) 1·12 (1·00–1·25)
Skin colour 
White 1 (ref) 1 (ref) 
Black 2·20 (1·50–3·22) 1·54 (1·31–1·82)
Brown 1·61 (1·17–2·23) 1·36 (1·19–1·55)
Asian 2·59 (0·86–7·83) 0·94 (0·52–1·70)
Indigenous 0·81 (0·33–1·99) 0·74 (0·41–1·33)
Low educational attainment 
No 1 (ref) 1 (ref) 
Yes 2·18 (1·71–2·78) 1·60 (1·44–1·78)
Tobacco use 
No 1 (ref) 1 (ref) 
Yes 1·15 (0·68–1·92) 1·26 (1·08–1·46)
Alcohol misuse
No 1 (ref) 1 (ref) 
Yes 0·99 (0·55–1·81) 1·11 (0·93–1·31)
Illicit drug use
No 1 (ref) 1 (ref) 
Yes 3·32 (2·06–5·35) 2·13 (1·84–2·46)
HIV
No 1 (ref) 1 (ref) 
Yes 4·63 (2·81–7·63) 2·74 (2·30–3·25)
Diabetes
No 1 (ref) 1 (ref) 
Yes 0·78 (0·22–2·75) 1·23 (0·76–1·97)
Extent of urbanisation
Rural 1 (ref) 1 (ref) 
Urban 1·03 (0·67–1·60) 1·21 (0·99–1·49)
Peri-urban 0·78 (0·15–4·12) 1·37 (0·86–2·21)
Region
Southeast 1 (ref) 1 (ref)
North 0·81 (0·58–1·13) 1·04 (0·89–1·20)
Northeast 0·86 (0·64–1·17) 0·85 (0·75–0·98)
South 0·82 (0·57–1·19) 0·96 (0·82–1·12)
Central-west 1·60 (0·90–2·83) 1·02 (0·80–1·31)
Homelessness
No 1 (ref) 1 (ref) 
Yes 1·26 (0·35–4·46) 3·32 (2·22–4·96)
(Table 4 continues in next column)
Adolescents aged 
10–17 years (n=3431)
Young adults aged 
18–24 years (n=11 619)
(Continued from previous column)
Deprivation of liberty
No 1 (ref) 1 (ref) 
Yes 1·28 (0·58–2·85) 0·55 (0·47–0·65)
Government cash transfers
No 1 (ref) 1 (ref)
Yes 0·66 (0·46–0·93) 0·91 (0·75–1·11)
Clinical features of tuberculosis
Extra-pulmonary 
tuberculosis
1 (ref) 1 (ref) 
Pulmonary 
tuberculosis
0·73 (0·54–0·98) 1·03 (0·87–1·22)
Data are adjusted odds ratio (95% CI). Associations were estimated by complete case 
analyses of adolescents and young adults (including the government cash transfers 
variable), using multivariate logistic regression models.
Table 4: Association between participant characteristics and 
unfavourable tuberculosis treatment outcomes—including government 
cash transfers variable
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São Paulo, Brazil, homeless adults with tuberculosis 
were more likely to experience loss to follow­up and 
death than the general population with tuberculosis.39
Conversely, deprivation of liberty was associated with a 
lower likelihood of unfavourable treatment outcome in 
our study—although this association only persisted 
for young adults. These findings align with those 
from Maciel and Reis­Santos,22 who suggested that 
adults with tuberculosis in Brazilian prisons were less 
likely to be lost to follow­up or die, probably because of 
closer institutionalised treatment supervision, focused 
tuberculosis screening, and contact tracing. It remains 
concerning that deprivation of liberty was prevalent 
among our study cohort. In 2014, it was estimated that 
juvenile detention centres in Brazil exceeded their 
maximum capacity by over 20%, which likely contributes 
to the risk of tuberculosis infection for young people.40
Young people who received governmental cash 
transfers had a decreased likelihood of unfavourable 
treatment outcome in our study, although this association 
was only detected for adolescents in the stratified 
analyses. The relevance of the stratified analysis is 
unclear given the extent of missing data for the 
government cash transfer variable in young adults. 
Adolescents are more likely to still reside at home and it 
is possible that other family members might be in receipt 
of additional government social protection schemes; 
therefore enhancing the observed effect of cash transfers. 
In this study, cash transfers were not specific to 
tuberculosis treatment programmes, and relate to 
separate inclusion criteria regarding household income 
and social deprivation. Young people were not adequately 
included in government cash transfers in this cohort, 
and this might reflect subtle disparities in accessibility 
and perceived eligibility or deservedness of young people 
to this form of social protection.
The scope of social protection, and specifically 
government cash transfers, is relevant to tuberculosis 
elimination efforts among young people. People with 
tuberculosis are susceptible to economic shocks and might 
be threatened by catastrophic costs during tuberculosis 
treatment.41 Our findings reinforce that targeting cash 
transfers to people with tuberculosis and their households 
can increase household income, reduce food insecurity, 
and improve tuberculosis treatment success rates.22,24,41–43 A 
systematic literature review and meta­analysis on the 
effects of social protection on tuberculosis treatment 
outcomes in low­income and middle­income settings, and 
in countries with high tuberculosis burden, found that 
social protection programmes were associated with 
tuberculosis treatment success (risk ratio [RR] 1·09, 
95% CI 1·03–1·14) and cure (RR 1·11, 1·01–1·22) as well as 
with reduced risk of loss to follow­up (RR 0·63, 0·45–0·89); 
yet these programmes were not significantly associated 
with treatment failure or mortality.44
Young people in more vulnerable groups are often 
underserved; and, as this study suggests, young people 
with tuberculosis—in particular those experiencing 
homelessness, living with HIV, using illicit drugs, or 
having lower educational attainment—were most likely 
to have an unfavourable treatment outcome. de Oliveira 
and colleagues45 sought to aggregate some of these 
characteristics as markers of extreme vulnerability, 
and found that adolescents presenting with either 
homelessness, incarceration, tobacco use, illicit drug 
use, or alcohol misuse were three times more likely 
to have an unfavourable outcome. However, further 
work is needed to better understand how to target 
young people with differing characteristics of extreme 
vulnerability through an intersectional approach in 
national tuberculosis policy, especially in the context of 
the ongoing COVID­19 pandemic and its effects on 
health and social systems.
Our study is also subject to limitations. This study 
used secondary clinical registry data that contained a 
considerable proportion of missing data (up to 43% in 
the government cash transfer variable). Young people 
with tuberculosis who had missing values attributed to 
their skin colour, education level, HIV status, or 
homelessness were significantly more likely to have an 
unfavourable tuberculosis treatment outcome in the 
sensitivity analysis. Therefore, the exclusion of missing 
values might have resulted in the underestimation of 
the association found for these variables of interest. 
Additionally, São Paulo state did not report data relating 
to all new variables introduced in 2015, including the 
government cash transfer variable. There is, therefore, a 
risk of bias and underestimation of the association 
found between the government cash transfer variable 
and unfavourable treatment outcome, particularly for 
young adults, in the stratified analyses. Although the 
extent and nature of missing data might limit the 
generalisability of our findings, the similar point 
estimates for adjusted odds ratios in the complete­case 
and missing indicator analyses suggest that there is little 
possibility of the missing data having interfered in our 
results (appendix pp 2–3).
We did not have information on important confounders, 
such as household income, in addition to information 
relating to HIV diagnosis (including viral load, CD4 
count, and time of initiation and co­administration of 
antiretroviral therapy). Additionally, it is unclear if loss 
of information about individuals who were transferred to 
other health­care centres was due to clinical need or 
change of home address due to unforeseen circumstances, 
and might have resulted in the inclusion of healthier or 
less vulnerable study participants in this study. Although 
we included change in treatment regimen (n=125) as 
an unfavourable treatment outcome, others might argue 
that changes in treatment regimen are common in 
usual tuberculosis management and care. However, this 
inclusion is unlikely to have resulted in the overestimation 
of the prevalence of unfavourable treatment outcomes in 
our study population.
See Online for appendix
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Amid upward trends in tuberculosis incidence for 
young adults, this study found that almost a fifth of 
young people with tuberculosis in Brazil had an 
unfavourable treatment outcome between 2015 and 2018. 
Race, poverty, and comorbidities were associated with 
a higher likelihood of unfavourable outcome, whereas 
being in receipt of government cash transfers was found 
to be protective. Our findings emphasise the need for 
individualised, patient­centred, and equitable tuberculosis 
care for young people.
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